MicroRNA-22 is down-regulated in hepatitis B virus-related hepatocellular carcinoma

Biomedicine and Pharmacotherapy

Volumn 67, Issue 5, 2013, Pages 375-380

  Shi, Cailing ^a   Xu, Xudong ^b  

^a Shandong Jining No 1 People's Hospital   (China)

^b JINING MEDICAL UNIVERSITY   (China)

Author keywords

CDKN1A; Hepatitis B virus (HBV); MicroRNAs; MiR 22

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; MICRORNA 22;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE COURSE; DOWN REGULATION; GENE EXPRESSION; GENE REPRESSION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN TARGETING; TUMOR SUPPRESSOR GENE;

CARCINOMA, HEPATOCELLULAR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISEASE PROGRESSION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MICRORNAS;

EID: 84878350898     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2013.03.002     Document Type: Article

References (26)

1. Seeff L.B., Hoofnagle J.H. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity. Oncogene 2006, 25:3771-3777.
2. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004, 11:97-107.
3. Liu D.X. A new hypothesis of pathogenetic mechanism of viral hepatitis B and C. Med Hypotheses 2001, 56:405-408.
4. Dominguez-Malagon H., Gaytan-Graham S. Hepatocellular carcinoma: an update. Ultrastruct Pathol 2001, 25:497-516.
5. Hobert O. Gene regulation by transcription factors and microRNAs. Science 2008, 319:1785-1786.
6. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
7. Foley N.H., Bray I., Watters K.M., et al. MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2. Cell Death Differ 2011, 18:1089-1098.
8. Gu J., Zhu X., Li Y., et al. miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines. Med Oncol 2011, 28:211-218.
9. Yang H., Fang Z., Wei Y., et al. Levels of miR-29b do not predict for response in patients with acute myelogenous leukemia treated with the combination of 5-azacytidine, valproic acid, and ATRA. Am J Hematol 2011, 86:237-238.
10. Iorio M.V., Ferracin M., Liu C.G., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65:7065-7070.
11. Iorio M.V., Visone R., Di Leva G., et al. MicroRNA signatures in human ovarian cancer. Cancer Res 2007, 67:8699-8707.
12. Wang G., Mao W., Zheng S. MicroRNA-183 regulates Ezrin expression in lung cancer cells. FEBS Lett 2008, 582:3663-3668.
13. Gao J.S., Zhang Y., Tang X., et al. The evi1, microRNA-143, K-Ras axis in colon cancer. FEBS Lett 2011, 585:693-699.
14. Hao J., Zhang S., Zhou Y., Hu X., Shao C. MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer. FEBS Lett 2011, 585:207-213.
15. Xiong J., Yu D., Wei N., et al. An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. FEBS J 2010, 277:1684-1694.
16. Zhang J., Yang Y., Yang T., et al. microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer 2010, 103:1215-1220.
17. Liu Y., Zhao J.J., Wang C.M., et al. Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line. Chinese Med J 2009, 122:10-14.
18. Wang W., Zhao L.J., Tan Y.X., Ren H., Qi Z.T. Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol 2012, 18:5442-5453.
19. Fan C.G., Wang C.M., Tian C., et al. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3. Oncol Rep 2011, 26:1281-1286.
20. Li C., Wang Y., Wang S., et al. HBV mRNAs-mediated miR-122 inhibition up-regulates PTTG1-binding protein which promotes HCC tumor growth and cell invasion. J Virol 2013, 87:2193-2205.
21. Chen S., Ni M., Yu B., Lv T., Lu M., Gong F. Construction and identification of a human liver specific microRNA eukaryotic expression vector. Cell Mol Immunol 2007, 4:473-477.
22. Su C., Hou Z., Zhang C., Tian Z., Zhang J. Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cells. Virol J 2011, 8:354.
23. Wang C.M., Wang Y., Fan C.G., et al. miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma. Biochem Biophys Res Commun 2011, 411:586-592.
24. Wei X., Xiang T., Ren G., et al. miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A. Cell Signal 2013, 25:439-446.
25. Li L.M., Hu Z.B., Zhou Z.X., et al. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 2010, 70:9798-9807.
26. Jin J., Tang S., Xia L., et al. MicroRNA-501 promotes HBV replication by targeting HBXIP. Biochem Biophys Res Commun 2013, 430:1228-1233.